Article
Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients.
Canadian journal of physiology and pharmacology - 1 Jan 2014
Hamzah Sharina, Teh Lay Kek, Siew John Shia Kwong, Ahmad Ghazali, Wong Hin Seng, Zakaria Zainul Amiruddin, Salleh Mohd Zaki
Abstract excerpt
Tacrolimus (FK506) is a calcineurin inhibitor with a narrow therapeutic index that exhibits large interindividual variation. Seventy-eight kidney transplant patients treated with tacrolimus were recruited to study the correlation of dose adjusted trough level (level/dose; L/D) of tacrolimus with CYP3A5 and ABCB1 genotypes, as well as the mRNA copy number of ABCB1 in blood. Patients were genotyped for ABCB1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
